Evaluation of Ischemia and Reperfusion Interval With Neuromonitorization in Tourniquet Application
Quadriceps Muscle Atrophy, Tourniquet, EMG
About this trial
This is an interventional diagnostic trial for Quadriceps Muscle Atrophy
Eligibility Criteria
Inclusion Criteria: Operation planning in the foot and ankle area Exclusion Criteria: Having a history of previous foot and ankle surgery, Having a history of previous knee surgery or spinal surgery, Diagnosis of diabetes mellitus, Having a known diagnosis of a disease affecting the peripheral nervous system (peripheral neuropathy, previous spinal surgery, stroke, etc.), Having a diagnosis of a disease affecting the known peripheral vascular system (Peripheral vascular disease, calcified popliteal artery, peripheral arterial bypass surgery, vasculitis, advanced chronic venous insufficiency), Having a disease that affects the ideal tourniquet application (Chronic Lymphedema, BMI>35, Stage 3 and above chronic renal failure, uncontrollable hypertension), Having been diagnosed with a known coagulation disorder, History of pulmonary embolism or deep vein thrombosis. ASA score above 3 Surgery time to be less than 80 minutes
Sites / Locations
- Department of Orthopaedics and Traumatology, Istanbul University, Istanbul, TurkeyRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
LOP + 50 mmHg
LOP + 100 mmHg
As a result of randomization, the surgical tourniquet pressure is 50 mmHg higher than the limb occlusion pressure. Limb occlusion pressure is calculated using the formulation by Graham: LOP = [(Systolic Pressure - Diastolic Pressure)× (Limb Diameter) / 3 Cuff Width)] + Diastolic Pressure
As a result of randomization, the surgical tourniquet pressure is 100 mmHg higher than the limb occlusion pressure. Limb occlusion pressure is calculated using the formulation by Graham: LOP = [(Systolic Pressure - Diastolic Pressure)× (Limb Diameter) / 3 Cuff Width)] + Diastolic Pressure